Clinical Trials on PIK3CA 突变型转移性乳腺癌 in France
总计1872个结果
-
Relay Therapeutics, Inc.招聘中乳腺癌 | 晚期乳腺癌 | 转移性乳腺癌 | 实体瘤,成人 | HER2 阴性乳腺癌 | 不可切除的实体瘤 | PIK3CA突变美国, 西班牙, 法国, 意大利
-
Gustave Roussy, Cancer Campus, Grand Paris完全的
-
Institut de Cancérologie de la LoireSaint-Louis Hospital, Paris, France; Gustave Roussy, Cancer Campus, Grand Paris撤销
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo招聘中晚期乳腺癌 | HER2阳性转移性乳腺癌 | 乳腺癌转移 | HER2低位乳腺癌法国
-
Institut de Recherches Internationales ServierADIR, a Servier Group company完全的
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo, Inc.招聘中
-
Centre Georges Francois LeclercSanofi; GlaxoSmithKline完全的
-
Institut Claudius RegaudFondation Toulouse Cancer Santé尚未招聘
-
Centre Francois Baclesse主动,不招人
-
UNICANCERClovis Oncology, Inc.; Fondation ARC完全的
-
Institut Paoli-CalmettesNovartis Pharmaceuticals招聘中
-
Centre Hospitalier Universitaire de BesanconNational Cancer Institute, France完全的
-
Centre Jean Perrin终止
-
Centre Jean Perrin终止
-
Centre Hospitalier Universitaire de Besancon完全的
-
UNICANCERMinistry of Health, France主动,不招人
-
ZionexaGE Healthcare; Simbec-Orion Group; Keosys招聘中
-
Institut Curie完全的
-
Novartis Pharmaceuticals终止
-
University of California, Irvine招聘中
-
Institut Claudius RegaudNovartis终止Metastatic Cancer (Different Solid Tumour Types)法国
-
UNICANCERNational Cancer Institute, France招聘中
-
Centre Leon BerardMerck Sharp & Dohme LLC完全的